Strattera Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder
Condition:   Adult Attention Deficit Hyperactivity Disorder Interventions:   Drug: OPC-64005;   Drug: Atomoxetine;   Drug: Placebo Sponsor:   Otsuka Pharmaceutical Development& Commercialization, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2017 Category: Research Source Type: clinical trials